IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

AGNELLI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.571
NA - Nord America 14.351
AS - Asia 10.956
Continente sconosciuto - Info sul continente non disponibili 1.746
SA - Sud America 936
AF - Africa 192
OC - Oceania 57
Totale 48.809
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.809
DE - Germania 9.759
GB - Regno Unito 3.994
CN - Cina 3.765
SG - Singapore 2.629
IT - Italia 2.071
SE - Svezia 1.138
RU - Federazione Russa 1.028
BD - Bangladesh 999
HK - Hong Kong 791
VN - Vietnam 752
FR - Francia 665
BR - Brasile 630
IN - India 593
UA - Ucraina 417
TR - Turchia 409
CA - Canada 385
NL - Olanda 373
KR - Corea 348
IE - Irlanda 316
FI - Finlandia 291
EU - Europa 241
JP - Giappone 172
CO - Colombia 152
ID - Indonesia 149
DK - Danimarca 87
PL - Polonia 84
CI - Costa d'Avorio 72
GR - Grecia 66
AR - Argentina 56
AU - Australia 49
IQ - Iraq 49
MX - Messico 49
ES - Italia 43
BE - Belgio 40
EC - Ecuador 30
AT - Austria 28
PK - Pakistan 28
CH - Svizzera 26
CY - Cipro 25
PH - Filippine 25
RO - Romania 24
UZ - Uzbekistan 24
EG - Egitto 22
MY - Malesia 22
ZA - Sudafrica 22
VE - Venezuela 21
CR - Costa Rica 20
JM - Giamaica 18
JO - Giordania 18
CZ - Repubblica Ceca 17
MA - Marocco 17
TW - Taiwan 17
AE - Emirati Arabi Uniti 16
IR - Iran 16
CL - Cile 15
SA - Arabia Saudita 15
IL - Israele 14
KE - Kenya 14
TH - Thailandia 14
NO - Norvegia 13
NP - Nepal 13
PE - Perù 11
PT - Portogallo 11
PY - Paraguay 11
TN - Tunisia 11
BG - Bulgaria 10
HU - Ungheria 10
TT - Trinidad e Tobago 10
GT - Guatemala 9
LT - Lituania 9
NI - Nicaragua 9
AL - Albania 8
AZ - Azerbaigian 8
GE - Georgia 7
HN - Honduras 7
NZ - Nuova Zelanda 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
LU - Lussemburgo 6
BO - Bolivia 5
DZ - Algeria 5
LB - Libano 5
PR - Porto Rico 5
SC - Seychelles 5
SV - El Salvador 5
TJ - Tagikistan 5
UY - Uruguay 5
BB - Barbados 4
BS - Bahamas 4
EE - Estonia 4
MD - Moldavia 4
PA - Panama 4
SN - Senegal 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BY - Bielorussia 3
CW - ???statistics.table.value.countryCode.CW??? 3
ET - Etiopia 3
Totale 47.245
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 6.860
Southend 3.459
Ashburn 1.613
Singapore 1.404
Beijing 870
Hong Kong 729
Chandler 717
San Jose 703
Council Bluffs 670
Boise 651
Seattle 637
Milan 627
Wilmington 443
Fairfield 439
Princeton 419
Dallas 374
Santa Clara 374
Jacksonville 345
Dublin 312
Houston 297
Dearborn 276
Woodbridge 276
Hanover 271
Los Angeles 263
Mountain View 248
Nanjing 237
Ho Chi Minh City 228
New York 220
Redmond 219
Bengaluru 207
Ann Arbor 203
Toronto 186
Lauterbourg 182
Cambridge 179
Guangzhou 175
Hanoi 172
Somerville 167
Shanghai 166
Buffalo 160
Boardman 152
Moscow 144
Des Moines 143
Serra 143
Andover 140
Sakarya 137
Bogotá 128
Hefei 118
Jinan 108
Helsinki 103
Shenyang 101
Tokyo 95
Rome 93
Berlin 92
Jakarta 92
Phoenix 90
Nanchang 83
São Paulo 82
Tianjin 79
Kiez 78
Columbus 76
Redwood City 76
Changsha 73
Abidjan 72
Cangzhou 67
The Dalles 67
Naples 65
Warsaw 63
Hebei 62
Hangzhou 59
Saint Petersburg 59
Athens 54
Zhengzhou 54
Nürnberg 53
Eitensheim 51
Wuhan 45
Munich 43
Roxbury 43
Chicago 42
Atlanta 40
Nuremberg 40
Grafing 39
London 39
Hamburg 38
Odernheim 37
Bitonto 36
Kunming 35
Orofino 35
San Diego 35
Chengdu 34
Da Nang 34
Seoul 34
Bologna 33
Shenzhen 33
Turin 33
Payette 32
Cottonwood 31
Fuzhou 31
Garden Valley 31
Rochester 31
San Francisco 31
Totale 30.065
Salva come PNG Salva come JPEG
Nome #
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells : a new attractive target 1.089
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide 1.029
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma 577
IMPROVED RISK STRATIFICATION IN MULTIPLE MYELOMA USING A MICRORNA-BASED CLASSIFIER 471
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 452
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 452
Targeted resequencing of FECH locus reveals that a novel deep intronic pathogenic variant and eQTLs may cause erythropoietic protoporphyria (EPP) through a methylation-dependent mechanism 424
A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma 420
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 418
Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing 397
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma 392
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma 383
Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia 382
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 371
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma 366
Prognostic significance of telomere length in chronic lymphocytic leukemia patients in early stage disease 361
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias : implication for MEK-ERK pathway activation 361
A distinctive trascriptional profile characterizes the chromosome 17p loss in B-cell chronic lymphocytic leukemia 355
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 349
The expression pattern of small nucleolar and small cajal body-specific RNAS characterizes distinct molecular subtypes of multiple myeloma 342
Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma 342
Disentangling the microRNA regulatory milieu in multiple myeloma : integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients 341
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 340
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 332
Molecular Classification of Multiple Myeloma : A Distinct Transcriptional Profile Characterizes Patients Expressing CCND1 and Negative for 14q32 Translocations 318
Long Non-Coding RNAs in Multiple Myeloma 317
Bone microenvironment cells reveal a different gene expression profiling in multiple myeloma patients as compared to healthy subjects : potential relationship with the bone status 314
Integrative genomic analysis of trisomy 12 abnormality in B-cell chronic lymphocytic leukemia 310
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 309
Analysis of CD44 expression in monoclonal gammopathies : correlation between gene expression level and flow cytometry findings 308
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia 308
Genome-wide approach identify recurrent 8p21.2 loss in more aggressive form of primary plasma-cell leukemia 306
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcomek 306
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma : an integrated genomics approach reveals a wide gene dosage effect 304
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 300
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma 300
Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia 298
A novel fish-based normalization procedure for whole genome microarrays detecting accurate local copy numbers : application to multiple myeloma 295
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles 294
Bone microenvironment cells reveals a different gene expression profyling in multiple myeloma patients in relation to the bone status 292
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 291
Impact of Host Genes and Strand Selection on miRNA and miRNA* Expression 290
Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome 289
A Compendium of Transcriptional and Mutational Data to Improve the Stratification of Peripheral T-Cell Lymphoma Subtypes 289
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia : a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 288
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 284
MicroRNA genes associated with genomic alterations or gene expression modulation contribute to enhance genetic heterogeneity in Multiple Myeloma 284
lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome 284
B-cell receptor configuration and adverse cytogenetics are associated to a higher risk of autoimmune hemolytic anemia in the course of chronic lymphocytic leukemia 283
Integration of Transcriptional and Mutational Data Simplifies the Stratification of Peripheral T-Cell Lymphoma 283
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma 282
Molecular classification and pharmacogenetics of primary plasma cell leukemia: an initial approach toward precision medicine 281
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes 279
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications 278
In silico characterization of miRNA and long non-coding RNA interplay in multiple myeloma 278
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 277
Gene Expression Profiling of Plasma Cell Dyscrasias Reveals Molecular Heterogeneity of Multiple Myeloma 276
Molecular definition of 17P11-P12 amplification in multiple myeloma 274
Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses 273
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia 273
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia 273
Patterns of global DNA methylation identify early stage (Binet A) CLL patients with higher risk of disease progression 272
Integrative genomics based on microarrays analyses reveals a correlation between allelic imbalances and gene expression patterns in multiple myeloma 269
11Q13 polisomy and absence of IGH translocations and chromosome 13Q14 deletion characterize a distinct subgroup of multiple myeloma patients expressing CCND 266
Peripheral T-Cell Lymphomas Not Otherwise Specified: Potential Novel Molecular Entities Based on Both Tumor and Microenvironment Cellular Components 260
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 259
Genome-wide DNA copy number analysis by SNP arrays of B-cell chronic lymphocytic leukemia reveals the presence of novel molecular lesions 257
High-resolution microarray characterization of the 13q14 deletion extent in B-cell chronic lymphocytic leukemia : correlation with copy number and expression levels of mir-15a/16 cluster 256
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 256
The prevalence and clinical implications of c-kit expression in plasma cell myeloma 255
A novel fish-based normalization procedure for whole genome microarrays detection accurate local copy numbers : application to multiple myeloma 255
Molecular classification of Multiple Myeloma : a distinct trascriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocation 255
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 252
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia 251
Genome-wide analysis of DNA copy number changes in multiple myeloma using high-density SNP arrays 249
Revealing the Impact of Structural Variants in Multiple Myeloma 249
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC) 246
Integrative genomic analysis of primary plasma cell leukemia revealed strong gene and microrna dosage effect 246
Are the myeloma bone microevironment cells tumoral or not? 245
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups 245
Analysis of Stereotyped IGHV distribution in a series of 1133 chronic lymphocytic leukemia patients : the experience of a multicenter Italian Study Group 245
Transcriptional features of 1Q in multiple myeloma 244
Molecular classification of multiple myeloma: a distinct profile characterizes patients expressing CCND1 and negative for 14q32 translocations 243
Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia 243
A retained transcriptomic profile characterizes CD138+ cells in the short time progression from smoldering to active multiple myeloma 242
Integrative genomic approach based on SNP-array and gene expression profiling reveals the presence of molecularly distinct subgroups in early stage b-cell chronic lymphocytic leukemia 241
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia 241
Integrative high-resolution microarrays approach in B-cell chronic lymphocytic leukemia reveals the presence of molecularly distinct subgroups in patients with 13Q deletion 239
The immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and rankl/opg ratio in myeloma microenvironment targeting the expression of adhesion molecules 239
The investigation of genomic profiles in plasma cell leukemias by means of an integrative microarray approach 238
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma 238
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia 237
Integrative Genomic Approach Identifies Deregulated MicroRNAs in Human Myeloma Cell Lines 236
Gene expression profiling of multiple myeloma : implications for a molecular classification of the disease 236
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups 235
The investigation of genomic profiles in primary plasma cell leukemias by means of an integrative microarray approach 235
Relevance of Ras gene mutations in the context of the molecular heterogeneity of multiple myeloma 234
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model 233
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples 233
Integrative genomic approach identifies deregulated micrornas in human myeloma cell lines 232
Totale 31.141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.798
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.173 0 0 0 149 245 185 282 170 354 206 134 448
2022/20232.742 411 263 223 270 317 545 87 166 235 55 112 58
2023/20246.235 55 136 91 166 478 275 946 863 427 871 933 994
2024/20256.202 897 828 756 692 247 160 154 439 254 404 365 1.006
2025/20269.503 878 598 883 733 786 574 1.097 464 940 615 1.100 835
2026/20273.075 769 649 692 965 0 0 0 0 0 0 0 0
Totale 48.809